Literature DB >> 22815502

TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity.

Clemence Blouet1, Shun-Mei Liu, Young-Hwan Jo, Streamson Chua, Gary J Schwartz.   

Abstract

Thioredoxin interacting protein (TXNIP) has recently been described as a key regulator of energy metabolism through pleiotropic actions that include nutrient sensing in the mediobasal hypothalamus (MBH). However, the role of TXNIP in neurochemically specific hypothalamic subpopulations and the circuits downstream from MBH TXNIP engaged to regulate energy homeostasis remain unexplored. To evaluate the metabolic role of TXNIP activity specifically within arcuate Agrp neurons, we generated Agrp-specific TXNIP gain-of-function and loss-of-function mouse models using Agrp-Ires-cre mice, TXNIP (flox/flox) mice, and a lentivector expressing the human TXNIP isoform conditionally in the presence of Cre recombinase. Overexpression of TXNIP in Agrp neurons predisposed to diet-induced obesity and adipose tissue storage by decreasing energy expenditure and spontaneous locomotion, without affecting food intake. Conversely, Agrp neuronal TXNIP deletion protected against diet-induced obesity and adipose tissue storage by increasing energy expenditure and spontaneous locomotion, also without affecting food intake. TXNIP overexpression in Agrp neurons did not primarily affect glycemic control, whereas deletion of TXNIP in Agrp neurons improved fasting glucose levels and glucose tolerance independently of its effects on body weight and adiposity. Bidirectional manipulation of TXNIP expression induced reciprocal changes in central leptin sensitivity and the neural regulation of lipolysis. Together, these results identify a critical role for TXNIP in Agrp neurons in mediating diet-induced obesity through the regulation of energy expenditure and adipose tissue metabolism, independently of food intake. They also reveal a previously unidentified role for Agrp neurons in the brain-adipose axis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815502      PMCID: PMC3486516          DOI: 10.1523/JNEUROSCI.0353-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons.

Authors:  T M Hahn; J F Breininger; D G Baskin; M W Schwartz
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

2.  Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.

Authors:  William A Chutkow; Richard T Lee
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

3.  Nutrient-sensing hypothalamic TXNIP links nutrient excess to energy imbalance in mice.

Authors:  Clémence Blouet; Gary J Schwartz
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

4.  Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus.

Authors:  J G Mercer; N Hoggard; L M Williams; C B Lawrence; L T Hannah; P J Morgan; P Trayhurn
Journal:  J Neuroendocrinol       Date:  1996-10       Impact factor: 3.627

5.  Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.

Authors:  William A Chutkow; Parth Patwari; Jun Yoshioka; Richard T Lee
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

6.  Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II.

Authors:  Philip J Scarpace; Michael Matheny; Sergei Zolotukhin; Nihal Tümer; Yi Zhang
Journal:  Neuropharmacology       Date:  2003-08       Impact factor: 5.250

7.  Lack of TXNIP protects beta-cells against glucotoxicity.

Authors:  Anath Shalev
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

8.  Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.

Authors:  Junqin Chen; Simon T Hui; Francesca M Couto; Imran N Mungrue; Dawn B Davis; Alan D Attie; Aldons J Lusis; Roger A Davis; Anath Shalev
Journal:  FASEB J       Date:  2008-06-13       Impact factor: 5.191

9.  Txnip balances metabolic and growth signaling via PTEN disulfide reduction.

Authors:  Simon T Y Hui; Allen M Andres; Amber K Miller; Nathanael J Spann; Douglas W Potter; Noah M Post; Amelia Z Chen; Sowbarnika Sachithanantham; Dae Young Jung; Jason K Kim; Roger A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

10.  The arrestin fold: variations on a theme.

Authors:  Laurence Aubry; Dorian Guetta; Gérard Klein
Journal:  Curr Genomics       Date:  2009-04       Impact factor: 2.236

View more
  24 in total

1.  Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Authors:  Lalit P Singh
Journal:  J Clin Exp Ophthalmol       Date:  2013-08-05

2.  SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity.

Authors:  Vanessa Schmidt; Nadja Schulz; Xin Yan; Annette Schürmann; Stefan Kempa; Matthias Kern; Matthias Blüher; Matthew N Poy; Gunilla Olivecrona; Thomas E Willnow
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

Review 3.  Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins.

Authors:  Ting Gong; Daniel J Torres; Marla J Berry; Matthew W Pitts
Journal:  Free Radic Biol Med       Date:  2018-03-05       Impact factor: 7.376

Review 4.  Remote control of glucose-sensing neurons to analyze glucose metabolism.

Authors:  Alexandra Alvarsson; Sarah A Stanley
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-05-29       Impact factor: 4.310

5.  Deletion of selenoprotein M leads to obesity without cognitive deficits.

Authors:  Matthew W Pitts; Mariclair A Reeves; Ann C Hashimoto; Ashley Ogawa; Penny Kremer; Lucia A Seale; Marla J Berry
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

Review 6.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

Review 7.  Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.

Authors:  Lance Thielen; Anath Shalev
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

Review 8.  Insights into obesity and diabetes at the intersection of mouse and human genetics.

Authors:  Melkam A Kebede; Alan D Attie
Journal:  Trends Endocrinol Metab       Date:  2014-07-15       Impact factor: 12.015

Review 9.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

10.  Developmental programming of appetite and growth in male rats increases hypothalamic serotonin (5-HT)5A receptor expression and sensitivity.

Authors:  Edward T Wargent; Malgorzata S Martin-Gronert; Roselle L Cripps; Lora K Heisler; Giles S H Yeo; Susan E Ozanne; Jonathan R S Arch; Claire J Stocker
Journal:  Int J Obes (Lond)       Date:  2020-07-27       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.